We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Crowdfunding Opportunities


Kings Mill Development Phase 2 - Interim Equity Housing and Property
An opportunity to invest in the development of a collection of stylish new homes consisting, in total, of 43x, 2 and 3 bed houses and 103x, 1 and 2 bed apartments.   This significant development by Prosperity will bring much needed housing stock to meet the demand from first time buyers as well as from the rental market. The development will be carried out in four phases and a proportion of each phase has been purchased by Prosperity to be sold onto investment buyers.   We are raising equity for the purchase of the site (Subject To Planning) in tranches linked to each Phase. Phase 2 will provide 17x, 2 bed houses and 3x, 3 bed houses, all to be completed within the first 18 months of the build program. All the 2 bed houses are pre-sold to Prosperity generating nearly £2m of sales revenue, and the 3 bed houses will be sold off-plan to local buyers.   The developer has secured the site and is contributing £300k of the total equity, with the remainder coming from CrowdLords Investors. In return for an investment in this Phase, holders of Redeemable Class C shares will receive 45.6% of their share of the projected profit which equates to around 39% of projected Phase 2 net profits, after tax. This will be paid as a capital gain when the shares are redeemed at a price of £1.30 per share, on or before the 28th February 2019.  
investment: £149,299 target: £333,300
status: Active
More Information
45%
Cloud-based SaaS software with the purpose of efficiently generating corporate management reports to reduce operational costs and improve data quality. Synapse's service can be implemented into pre-existing financial reporting systems to produce automated reports, even in large companies. Customers include Lloyds Bank, who have signed a 2-year term and the Bank of England have contacted Synapse to potentially integrate the system.
investment: £883,573 target: £900,010
status: Active
More Information
98%
Bivictrix Therapeutics Limited Medical EIS SEIS
BiVictriX Therapeutics is a pharmaceutical company that are developing ADC's (Antibody Drug Conjugates) in the field of Oncology. They have invented a strategy that improves ADC selectivity towards cancer cells.
investment: £451,506 target: £430,000 pre-money valuation: £4,347,778
status: Extended
More Information
105%
Prosperity House - 2x 2 Bed BTLs Housing and Property
These two high quality, two bedroom apartments have been completed as part of the first phase of development at Prosperity House. They have been provided by Prosperity at a signficant discount and have been taken up by an experienced LandLord who is also a CrowdLords member. The LandLord has a portfolio of 23 other properties in various locations around the country including one nearby in Nottingham. He has decided to offer Interim Equity for a period of 12 months after which time he will decide whether to sell or refinance the apartments. In return for their investment Investors enjoy a share of income and a share of any capital gain at the end of the investment term. With this investment the Income yield is paid quarterly and is projected to be 2.8% p.a. paid by way of Dividend, and the capital gain will be a share of 75% of the increase in vale, projected to combine to deliver a total return of 21.3%..
investment: £140,225 target: £143,800
status: Active
More Information
98%
 AskIf is platform that provides loan funding to small businesses. Each borrower has one or more relationship managers they can talk to. They are collecting data around social impact and are planning on monetising the data within their own business model and also to external stakeholders. AskIf will use the funding to expand referral partnership, increase the amount of their lending partners that are using the platform, make strong relationships to bring in new tech resource in house and bring in loan capital. 
investment: £668,753 target: £399,995 pre-money valuation: £3,001,323
status: Extended
More Information
167%
Using a person's face, the next generation of push notification allows a company to send and receive video and audio messages through the service to improve engagement and build trust with their business partners. 2Mee has attained a contract with a prominent gaming company, as well as six other clients taking a keen interest in the product and potentially licensing the IP.
investment: £411,620 target: £300,000 pre-money valuation: £4,197,751
status: Stretch
More Information
137%
Pertinax Pharma Medical EIS
Infections can be reduced and patient quality of life can be improved by using antimicrobial wound care materials developed by Pertinax. In vitro studies have already been performed using the company's development across multiple applications.
investment: £616,916 target: £699,997 pre-money valuation: £1,799,992
status: Active
More Information
88%
Driftrock are a digitasl media media marketing company who specialise in creating simple easy to use advertising tools.
investment: £800,278 target: £600,002 pre-money valuation: £5,702,540
status: Stretch
More Information
133%
Redag Crop Protection Limited Catering, Food and Drink EIS
Redag Crop is an agrochemical discovery business focused on products that play a vital role in controlling the pests and diseases that threaten our global food supply. The growing population, expected to grow by 8 billion by 2020 and then 9 billion by 2050, will need more crops than the existing land can produce. Each hectare will need to produce 2.5 times as many crops as they do now. 
investment: £1,250,000 target: £1,250,000 pre-money valuation: £12,638,889
status: Extended
More Information
100%
Funnel Music is a Music Rights and distribution business, designed to harness the power of modern technology in the music industry. Funnel’s unique business model will disrupt the sector through introducing considerable cost savings to the creation and commercialisation of an artist through Funnel’s ‘Shared Outcome Model’ thus providing sustainable long-term revenues for itself and the artists it engages with.
investment: £85,000 target: £85,000 pre-money valuation: £859,444
status: Extended
More Information
100%
KiteEdge's Apex Technology EIS
Kite edge has created a cognitive search service which has been built to specifically meet the needs of asset managers. Individuals can search and set up feeds that draw insight from their specific work (email, news, investment research, internal documents)
investment: £433,000 target: £600,000 pre-money valuation: £2,694,893
status: Funded
More Information
72%
ADC Biotechnology Limited Technology EIS
ADC Biotechnology provides specialist drug manufacturing services based on its own patented Lock-Release™ processing technology, focused on a new wave of oncology therapeutics called antibody-drug conjugates (“ADCs”) being developed by pharmaceutical companies worldwide.
investment: £6,243,502 target: £6,000,000 pre-money valuation: £60,666,667
status: Extended
More Information
104%
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph